Skip to content

Distinct Neurochemical Signature of Mindfulness and Progressive Muscle Relaxation in limbic regions: a randomized controlled MR spectroscopy study

Quentin Beaufort, Lucie Angel, Laurent Barantin, Frédéric Andersson, Valérie Gissot, Eva Sizaret, Floriane Le Vilain-Abraham, Wissam El-Hage, Jean-Philippe Cottier

Research Square November 13, 2025 preprint DOI: 10.21203/rs.3.rs-7722934/v1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized, pre-post study
Sample size 30
Population Healthy right-handed female speech-language therapy students
Interventions Mindfulness training Progressive muscle relaxation
Duration Six weeks
Measures Short-echo time single-voxel H1-MRS (3T PRESS, TE ≈ 35 ms), structural MRI
Topics Meditation
Key points Mindfulness training, but not progressive muscle relaxation, was associated with selective neurochemical changes: increased NAAG and total creatine and reduced glutamine and glycine in the posterior cingulate cortex, plus decreased NAAG in the amygdala. No metabolite changes appeared in the hippocampus or dorsal anterior cingulate cortex, and no structural brain changes were detected. The authors propose NAAG modulation as a candidate biomarker of contemplative practice.

Abstract

Abstract Mindfulness training (MT) and progressive muscle relaxation (PMR) are widely used stress-reduction practices, yet their neurochemical specificity remains almost unexplored. In a randomized, pre–post study, 30 healthy right-handed female speech-language therapy students were assigned to six weeks of MT or PMR. Short-echo time single-voxel H 1 -MRS (3T PRESS, TE ≈ 35 ms) and structural MRI were acquired at baseline and post-intervention. Four voxels were placed in the right amygdala, left hippocampus, right dorsal anterior cingulate cortex (dACC), and right posterior cingulate cortex (PCC); spectra were quantified with standard procedures (Osprey).Relative to baseline, MT produced increased N-acetyl-aspartyl-glutamate (NAAG) and total creatine (tCr) in the PCC, accompanied by reductions in glutamine (Gln) and glycine (Gly). In the amygdala, NAAG decreased following MT. No significant metabolite changes were observed in the PMR group, and no effects emerged in the hippocampal or dACC voxels in either group. Whole-brain morphometry showed no detectable structural change over the six-week interval.Overall, these findings indicate that mindfulness—but not PMR—was associated with a selective neurochemical rebalancing at the limbic–default mode network interface, consistent with phenomenological and network-level accounts of mindfulness. NAAG modulation, in particular, may represent a candidate biomarker of contemplative practice.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics